Coherus Biosciences Inc (CHRS) is higher by 3.23% Friday In Premarket Trading

Coherus Biosciences Inc (CHRS) is up Friday morning, with the stock gaining 3.23% in pre-market trading to 2.24. CHRS's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 99 out of 146 industries, the stock ranks higher than 4% of stocks. Coherus Biosciences Inc has fallen 15.23% over the past month, closing at $2.76 on February 16. During this period of time, the stock fell as low as $2.18 and as high as $2.85. CHRS has an average analyst recommendation of Strong Buy. The company has an average price target of $9.00.

CHRS has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CHRS!

See Full CHRS Report

Coherus Biosciences Inc has a Long-Term Technical rank of 8. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 92% of the market scoring higher. In the Biotechnology industry which is number 74 by this metric, CHRS ranks better than 74% of stocks.

Important Dates for Investors in CHRS:

-Coherus Biosciences Inc is set to release earnings on 2024-06-11. Over the last 12 months, the company has reported EPS of $-2.62. -We do not have a set dividend date for Coherus Biosciences Inc at this time. Click Here To Get The Full Report on Coherus Biosciences Inc (CHRS)